Skip to content

Evaluation of a Postcoital Sponge on Self-Reported Vaginal Health Parameters

Evaluation of a Postcoital Sponge on Self-Reported Vaginal Health Parameters

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06530186
Enrollment
1000
Registered
2024-07-31
Start date
2024-08-01
Completion date
2025-01-31
Last updated
2024-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sexual Dysfunction, Vaginal Discharge, Vaginal Infection, Vaginosis

Keywords

vaginal odor, vaginal discharge, postcoital dripping, vaginal microbiome

Brief summary

LiviWell has developed a product designed for postcoital semen absorption. Previous studies have demonstrated the product rapidly absorbs semen, and leads to less symptoms of postcoital vaginal microbiome disruption such as vaginal odor and discharge. This study will investigate the study device, Livi, in a broader clinical setting.

Detailed description

LiviWell's consumer hygiene device is a post-coital vaginal insert called Livi. Livi is comprised of an applicator, with a medical-grade polyurethane foam and retrieval string. It is designed to be inserted into the vagina after intercourse to absorb semen deposited into the vaginal canal. The result is a decrease in discharge/dripping and vaginal odor. The investigators also believe the device will lower vaginal pH, as the typical premenopausal vaginal pH is acidic (pH \ 4), and semen has an alkaline pH (\ 8). The resulting pH imbalance in sexually-active women not using male condoms had been shown to lead to vaginal odor, dripping, discomfort. Furthermore, the risk of bacterial vaginosis (BV) is higher in women who are sexually active and not using male condoms. The investigators have additional studies planned to evaluate if the product lowers the risk of BV. The current study will be used to validate user needs requirements for the study device, understand pH changes after insertion, and evaluate change in symptoms of vaginal odor, discharge/dripping, and discomfort, common symptoms of vaginal microbiome disruption and bacterial vaginosis.

Interventions

DEVICELiviWell Postcoital Vaginal Insert

subjects will use Livi within minutes of completion of sex, and will remove study device in under an hour.

Sponsors

Atlantic Health System
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Over 18 (for pH subset, 18-45) * Sexually-active with biological men * Willing and able to use product * Resides in continental USA * Understands, reads, writes, and speaks English

Exclusion criteria

* Currently Pregnant or are trying to conceive * Unable to use device due to poor motor function * Unable to sign informed consent

Design outcomes

Primary

MeasureTime frameDescription
User Experience Questionnaire24 hoursValidation of User Needs Requirements as well as patient experience

Secondary

MeasureTime frameDescription
change in vaginal pH2-6 hours, and 10-14 hours after usechange in vaginal pH before and after using Livi, and before and after NOT using Livi

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 1, 2026